View Press Releases
-
A.C. Camargo Cancer Center Harnesses the Power of DoseMe Precision Dosing Platform to Substantially Reduce Toxicity and Kidney Injuries
oseMe, a leading provider of precision dosing software for therapeutic drug monitoring (TDM) and creators of DoseMeRx and DoseMe Analytics, today announced AC Camargo Cancer Center continues to recognize improved patient care with real world data dosing results.
Aug 29, 2023
-
CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service
-
Breaking Ground: CD Formulation announces 90+ Active Pharmaceutical Ingredients Lineup
-
Creative Biolabs Updated Autoantigen Microarray Solution to Fuel Autoimmune Research
Creative Biolabs updated its NAA solution, which was designed to provide invaluable insights into autoimmune diseases and autoantibody profiling and promises to propel the field of autoimmune research forward.
Aug 25, 2023
-
BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research
BOC Sciences, a leading supplier of research chemicals and custom services, has unveiled its innovative XDC bioconjugation platform, providing a significant tool for drug delivery.
Aug 27, 2023
-
Alfa Chemistry Leads the Way in Tailored Preclinical Drug Research Solutions
-
IntelliGuard Appoints Robert Howard as CEO and Thomas Koning as President to Execute on Strategy of Continued Growth
IntelliGuard, a provider of medication and inventory management solutions, is strengthening its leadership team with the appointment of Bob Howard as Chief Executive Officer and Tom Koning as President. Founded in 2006, San Diego-based IntelliGuard provides hospitals with a more efficient and effective system for tracking, tracing, and managing medications and critical inventory to improve patient safety. Their approach to inventory management is particularly relevant right now with ongoing drug shortages.
Aug 22, 2023
-
Multi-protein Expression Service in Insect Cells Now Available at Profacgen
-
Creative BioMart Updated Its R-PEAPC Conjugated Proteins for Research Use
-
Creative Proteomics Debuts Far-Western Blot Analysis Service to Advance Proteomics Research
-
Creative Proteomics Launches Advanced Exosome Isolation and Purification Service
-
Exploring New Frontiers in Drug Delivery: CD Formulation Introduces State-of-the-Art Microsphere and Microneedle Technologies
-
Alfa Chemistry Launches a New Blog Section: Sharing Chemical Uses, Chemistry Information and News
-
Fast Company Names Linus Health’s DCTclock™ a Winner in 2023 Innovation by Design Awards
Revolutionary Digital Cognitive Assessment Recognized for Exceptional User Experience
Aug 21, 2023
-
STARLIMS Acquires Labstep, Expanding Its Portfolio Across R&D Through Product Commercialization
STARLIMS acquires Labstep, expanding its portfolio across R&D through product commercialization. Labstep’s Electronic Laboratory Notebook will deliver deeper R&D capabilities to support customers in ideation phase of product development.
Aug 21, 2023
-
Katie Coleman promoted to Head of Ashfield Event Experiences US, part of Inizio Engage XD
-
X-Chem Appoints Chief Scientific Officer and Chief Financial Officer
-
Biopharma PEG Supplies High Quality Cholesterol (Plant-Derived)
About us Biopharma PEG Scientific Inc. is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity monodispersed and polydispersed polyethylene glycol (PEG) derivatives and PEG raw material, PEGylation services, and custom PEG derivative synthesis to clients worldwide. We continuously expand the capability to provide large-scale manufacture of high purity PEG derivatives with an extensive variety of functional groups, in both non-GMP and GMP grade. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/
Aug 20, 2023
-
Qlucore recognized by strategic innovation program for MedTech
-
HONEYWELL AND RECIPHARM TO SPEED DEVELOPMENT OF INHALERS WITH A NEAR-ZERO GLOBAL WARMING POTENTIAL PROPELLANT
Partnership speeds development of inhalers with a near-zero global warming potential propellant
Aug 21, 2023